H. Nakagawa

发表

S. Akazaki, H. Nakagawa, H. Kazama, 2002, The British journal of dermatology.

Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle‐controlled, multicenter clinical trial

H. Nakagawa, M. Furue, Nobukazu Hayashi, 2014, The Journal of dermatology.

An Antibody to BP 180 kDa Antigen is Able to Induce an Increase of Intracellular Ca 2+ Concentration in DJM-1 (Human Squamous Cell Carcinoma) Cells

H. Nakagawa, S. Murata, H. Yaoita, 2002, Autoimmunity.

Bullous pemphigoid IgG2 and IgG4 antibodies have a capability to inhibit a transient increase of intracellular Ca2+ induced by bullous pemphigoid IgG1 antibody.

H. Nakagawa, H. Yaoita, M. Suzuki, 1999, Autoimmunity.

Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study.

H. Nakagawa, K. Kabashima, A. Igarashi, 2021, Journal of the American Academy of Dermatology.

Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study.

H. Nakagawa, A. Igarashi, H. Saeki, 2020, Journal of the American Academy of Dermatology.

Phase 2 clinical study of delgocitinib ointment in pediatric patients with atopic dermatitis.

H. Nakagawa, K. Kabashima, A. Igarashi, 2019, The Journal of allergy and clinical immunology.

Long‐term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis

H. Nakagawa, A. Igarashi, H. Saeki, 2019, The Journal of dermatology.

Phase 1 studies to assess the safety, tolerability and pharmacokinetics of JTE‐052 (a novel Janus kinase inhibitor) ointment in Japanese healthy volunteers and patients with atopic dermatitis

H. Nakagawa, N. Ninomiya, O. Nemoto, 2018, The Journal of dermatology.

Efficacy and safety of topical JTE‐052, a Janus kinase inhibitor, in Japanese adult patients with moderate‐to‐severe atopic dermatitis: a phase II, multicentre, randomized, vehicle‐controlled clinical study

H. Nakagawa, A. Igarashi, O. Nemoto, 2018, British Journal of Dermatology.

Efficacy and safety of dose escalation of infliximab therapy in Japanese patients with psoriasis: Results of the SPREAD study

A. Utani, H. Nakagawa, M. Muto, 2016, The Journal of dermatology.

Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52‐week, open‐label, phase 3 study (UNCOVER‐J)

H. Nakagawa, K. Sayama, Koichiro Nakamura, 2016, The Journal of dermatology.

Efficacy and safety of open‐label ixekizumab treatment in Japanese patients with moderate‐to‐severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis

H. Nakagawa, T. Ishii, M. Heffernan, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Long‐term study of infliximab in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma

H. Nakagawa, H. Torii, 2011, The Journal of dermatology.

Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial.

H. Nakagawa, H. Torii, 2010, Journal of dermatological science.

Case of metastatic malignant melanoma associated with hypertrophic osteoarthropathy

H. Nakagawa, Y. Nobeyama, 2013, The Journal of dermatology.

Gene gun–mediated oral mucosal transfer of interleukin 12 cDNA coupled with an irradiated melanoma vaccine in a hamster model: Successful treatment of oral melanoma and distant skin lesion

H. Nakagawa, Y. Jinbu, M. Ohtsuki, 2001, Cancer Gene Therapy.

Secukinumab efficacy and safety in Japanese patients with moderate‐to‐severe plaque psoriasis: Subanalysis from ERASURE, a randomized, placebo‐controlled, phase 3 study

H. Nakagawa, Hidetoshi Takahashi, M. Ohtsuki, 2014, The Journal of dermatology.

Molecular genetic analysis of HLA class II alleles in Japanese patients with melanoma.

H. Inoko, H. Nakagawa, M. Ichihashi, 1997, Tissue antigens.

Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis.

H. Nakagawa, H. Iizuka, O. Nemoto, 2020, Journal of dermatological science.

The first trial of CIM331, a humanized antihuman interleukin‐31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double‐blind, placebo‐controlled study

H. Nakagawa, M. Furue, K. Kabashima, 2016, The British journal of dermatology.

Guidelines for the diagnosis and treatment of vitiligo in Japan

H. Nakagawa, M. Wataya-Kaneda, C. Nishigori, 2013, The Journal of dermatology.

Detection of Merkel cell polyomavirus in Merkel cell carcinoma and Kaposi's sarcoma

H. Nakagawa, T. Tsuji, Hideki Ito, 2009, Journal of medical virology.

Nuclear localization of Merkel cell polyomavirus large T antigen in Merkel cell carcinoma.

H. Nakagawa, T. Tsuji, Hideki Ito, 2010, Virology.

Silencing of tissue factor pathway inhibitor‐2 gene in malignant melanomas

Y. Miyagi, H. Nakagawa, T. Ushijima, 2007, International journal of cancer.

Cyclosporin-MEPC for Treatment of Psoriasis: Questionnaire Survey on Members of Western Division of Japanese Dermatological Association

H. Nakagawa, J. Nakayama, A. Ozawa, 2005 .

Impact of obesity on the efficacy of ustekinumab in Japanese patients with psoriasis: a retrospective cohort study of 111 patients

H. Nakagawa, Y. Umezawa, K. Yanaba, 2014, Archives of Dermatological Research.

Detection of Calcium Binding Sites in Merkel Cell Granules of Fetal Rat Skin

H. Nakagawa, Y. Ishibashi, M. Nindl, 1989, The Journal of dermatology.

Evaluation of epicardial adipose tissue volume and coronary artery calcification in Japanese patients with psoriasis vulgaris

H. Nakagawa, Y. Umezawa, A. Asahina, 2018, The Journal of dermatology.

Tildrakizumab (MK‐3222), an anti‐interleukin‐23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo‐controlled trial

A. Gottlieb, H. Nakagawa, K. Papp, 2015, The British journal of dermatology.

Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.

S. Toda, H. Nakagawa, M. Ohtsuki, 2001, Biochemical and biophysical research communications.

Long‐Term Continuous versus Intermittent Cyclosporin: Therapy for Psoriasis

H. Nakagawa, K. Urabe, M. Ohtsuki, 2003, The Journal of dermatology.

The Origin and Fate of Merkel Cell Granules

H. Nakagawa, Y. Ishibashi, M. Nindl, 1990, The Journal of dermatology.

Analysis of HLA class II and TAP alleles in Japanese patients with psoriasis vulgaris.

H. Nakagawa, T. Juji, Y. Shibata, 1998, Human immunology.

Analysis of disease-associated amino acid epitopes on HLA class II molecules in atopic dermatitis.

H. Nakagawa, K. Tokunaga, T. Juji, 1995, The Journal of allergy and clinical immunology.

Retiform hemangioendothelioma treated with conservative therapy: report of a case and review of the literature

H. Nakagawa, Y. Ishiuji, Y. Nobeyama, 2016, International journal of dermatology.

Properdin Factor B Allotypes in Japanese Patients with Psoriasis

H. Nakagawa, K. Tokunaga, Y. Ishibashi, 1987, The Journal of dermatology.

Corneodesmosin (CDSN) gene association with psoriasis vulgaris in Caucasian but not in Japanese populations

S. Fisher, C. M. Lewis, H. Nakagawa, 2005, Clincal and Experimental Dermatology.

Ocular abnormalities associated with cutaneous melanoma and vitiligolike leukoderma

T. Fitzpatrick, H. Nakagawa, A. Sober, 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

Complete remission of metastatic clear cell sarcoma with DAV chemotherapy

H. Nakagawa, M. Fujimoto, T. Kiyosawa, 2003, Clinical and experimental dermatology.

Japanese guidance for use of biologics for psoriasis (the 2019 version)

H. Nakagawa, M. Komine, M. Ohtsuki, 2020, The Journal of dermatology.

Guselkumab, an anti‐interleukin‐23 monoclonal antibody, for the treatment of moderate to severe plaque‐type psoriasis in Japanese patients: Efficacy and safety results from a phase 3, randomized, double‐blind, placebo‐controlled study

H. Nakagawa, M. Ohtsuki, Ryosuke Goto, 2018, The Journal of dermatology.

Adalimumab treatment optimization for psoriasis: Results of a long‐term phase 2/3 Japanese study

H. Nakagawa, M. Ohtsuki, M. Okun, 2015, The Journal of dermatology.

Algorithm for Selecting Ideal Biologic Treatment for Psoriasis

H. Nakagawa, Y. Umezawa, K. Yanaba, 2015 .

Biologic therapy improves psoriasis by decreasing the activity of monocytes and neutrophils

H. Nakagawa, Y. Umezawa, E. Gabazza, 2014, The Journal of dermatology.

Impact of ustekinumab on health‐related quality of life in Japanese patients with moderate‐to‐severe plaque psoriasis: Results from a randomized, double‐blind, placebo‐controlled phase 2 / 3 trial

H. Nakagawa, A. Igarashi, Takeshi Kato, 2012, The Journal of dermatology.

Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: An analysis of Japanese clinical trials of infliximab

H. Nakagawa, H. Torii, T. Yoshinari, 2012, The Journal of dermatology.

Study of aspartate at residue 9 of HLA-C molecules in Japanese patients with psoriasis vulgaris.

H. Nakagawa, K. Tokunaga, T. Juji, 1996, Journal of dermatological science.

Effect of anti‐interleukin‐17 biologics on Krebs von den Lungen‐6 level in patients with psoriasis

H. Nakagawa, K. Kuwano, Y. Umezawa, 2021, The Journal of dermatology.

Comparative cut-off value setting of pruritus intensity in visual analogue scale and verbal rating scale.

H. Nakagawa, S. Takeuchi, M. Furue, 2015, Acta dermato-venereologica.

A case of anti‐p200 pemphigoid clinically mimicking inflammatory epidermolysis bullosa acquisita

H. Nakagawa, T. Hashimoto, T. Demitsu, 2003, The British journal of dermatology.

High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids.

H. Nakagawa, I. Katayama, S. Harada, 2002, European journal of dermatology : EJD.

Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris.

H. Nakagawa, Y. Miyachi, S. Harada, 2002, European journal of dermatology : EJD.

Novel mutation c.263A>G in the ACVRL1 gene in a Japanese patient with hereditary hemorrhagic telangiectasia 2

H. Nakagawa, M. Itoh, D. Sawamura, 2018, The Journal of dermatology.

Eruptive vellus hair cysts with sebaceous glands

H. Nakagawa, Y. Ishibashi, H. Chi, 1991, The British journal of dermatology.

Two new XPD patients compound heterozygous for the same mutation demonstrate diverse clinical features.

H. Nakagawa, A. Lehmann, M. Momoi, 2005, The Journal of investigative dermatology.

Specific nucleotide sequence of HLA-C is strongly associated with psoriasis vulgaris.

S. Akazaki, H. Nakagawa, K. Tokunaga, 1991, The Journal of investigative dermatology.

Serum C‐reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: Long‐term differential effects of biologics

H. Nakagawa, Y. Umezawa, K. Yanaba, 2016, The Journal of dermatology.

Interferon-Gamma-Induced RANTES Production by Human Keratinocytes Is Enhanced by IL-1β, TNF-α, IL-4 and IL-13 and Is Inhibited by Dexamethasone and Tacrolimus

H. Nakagawa, Koichiro Nakamura, K. Tamaki, 2001, Dermatology.

Genetic polymorphisms in the IL22 gene are associated with psoriasis vulgaris in a Japanese population.

Yusuke Nakamura, H. Nakagawa, S. Takeuchi, 2013, Journal of dermatological science.

Long‐term efficacy and safety of secukinumab in Japanese patients with moderate to severe plaque psoriasis: 3‐year results of a double‐blind extension study

H. Nakagawa, M. Ohtsuki, A. Morita, 2019, The Journal of dermatology.

Subanalysis of Efficacy by Body Region and Sign and Safety by Body Region of Delgocitinib Ointment

H. Nakagawa, A. Igarashi, 2021, Journal of the Japan Organization of Clinical Dermatologists.

Impact of anti‐tumor necrosis factor‐α agents on serum levels of KL‐6 and surfactant protein‐D in patients with psoriasis

H. Nakagawa, Y. Umezawa, K. Yanaba, 2017, The Journal of dermatology.

Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: Effect of Demographics and Baseline Disease Characteristics on Efficacy

H. Nakagawa, Y. Umezawa, S. Imafuku, 2021, Dermatology and Therapy.

Some clinical factors affecting quality of the response to ustekinumab for psoriasis

H. Nakagawa, Y. Umezawa, H. Saeki, 2014, The Journal of dermatology.

Superiority of magnetic resonance imaging over conventional radiography in the early diagnosis of psoriatic arthritis

H. Nakagawa, Y. Umezawa, K. Yanaba, 2017, The Journal of dermatology.

Four cases of Japanese patients with psoriatic arthritis in whom effective treatments by anti‐tumor necrosis factor‐α drugs were evaluated by magnetic resonance imaging together with improvement of skin lesions

H. Nakagawa, Y. Umezawa, K. Yanaba, 2015, The Journal of dermatology.

Case of psoriatic patient who maintains long‐term remission after anti‐hepatitis C virus agents and ustekinumab treatment

H. Nakagawa, Y. Umezawa, A. Asahina, 2018, The Journal of dermatology.

Characteristic alterations of cutaneous neurogenic factors in photoaged skin

H. Nakagawa, M. Morohashi, M. Toyoda, 2005, The British journal of dermatology.

Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1‐week randomized, multicentre, double‐blind, placebo‐controlled, parallel‐group study

T. Tango, H. Nakagawa, M. Kawashima, 2003, The British journal of dermatology.

Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study

H. Nakagawa, M. Ohtsuki, A. Asahina, 2010, The Journal of dermatology.

HLA-DM gene polymorphisms in atopic dermatitis.

H. Nakagawa, T. Juji, H. Saeki, 1996, The Journal of allergy and clinical immunology.

IL-10-producing regulatory B cells are decreased in patients with psoriasis.

H. Nakagawa, Y. Umezawa, K. Yanaba, 2016, Journal of dermatological science.

Case of desmoplastic melanoma with lung metastasis maintaining complete response after cessation of nivolumab

H. Nakagawa, K. Tanito, M. Itoh, 2017, The Journal of dermatology.

Biologic treatments for elderly patients with psoriasis

H. Nakagawa, Y. Umezawa, K. Yanaba, 2017, The Journal of dermatology.

The Changes of Lateral Diffusion Coefficients on the Keratinocytic Plasma Membrane by Bullous Pemphigoid IgG Subclasses

H. Nakagawa, H. Yaoita, Masayuki Suzuki, 2001 .

Relationship between serum trough levels and efficacy of brodalumab from a post hoc exploratory analysis of a Japanese study in patients with plaque psoriasis

Y. Yamaguchi, H. Nakagawa, Yasumasa Kanai, 2020, The Journal of dermatology.

Associations of TNFAIP3 variants with susceptibility to psoriasis vulgaris and psoriasis arthritis in a Japanese population.

H. Nakagawa, Y. Umezawa, M. Tamari, 2020, Journal of dermatological science.

Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: 52-Week Results

H. Nakagawa, Y. Umezawa, S. Imafuku, 2021, Dermatology and Therapy.

Exacerbation of atopic dermatitis symptoms by ustekinumab in psoriatic patients with elevated serum immunoglobulin E levels: Report of two cases

H. Nakagawa, Y. Umezawa, K. Yanaba, 2018, The Journal of dermatology.

Efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 64‐week phase 3 study (reSURFACE 1)

H. Nakagawa, M. Honma, M. Ohtsuki, 2021, The Journal of dermatology.

A Keratin 9 Gene Mutation (Asn160Ser) in a Japanese Patient with Epidermolytic Palmoplantar Keratoderma

H. Nakagawa, M. Komine, K. Tamaki, 2002, The Journal of dermatology.

Xeroderma pigmentosum complementation group F: Report of a case and review of Japanese patients

H. Nakagawa, S. Moriwaki, Y. Nobeyama, 2015, The Journal of dermatology.

An association study of 36 psoriasis susceptibility loci for psoriasis vulgaris and atopic dermatitis in a Japanese population.

H. Nakagawa, S. Fujieda, S. Takeuchi, 2014, Journal of dermatological science.

Long-lasting gene expression by particle-mediated intramuscular transfection modified with bupivacaine: combinatorial gene therapy with IL-12 and IL-18 cDNA against rat sarcoma at a distant site

H. Nakagawa, M. Ohtsuki, Y. Hoshino, 2003, Cancer Gene Therapy.

Long‐term safety of brodalumab in Japanese patients with plaque psoriasis: An open‐label extension study

Y. Yamaguchi, H. Nakagawa, K. Ootaki, 2020, The Journal of dermatology.

Clinical significance of serum soluble T‐cell immunoglobulin and mucin domain 3 levels in systemic sclerosis: Association with disease severity

H. Nakagawa, K. Yanaba, Yuki Yoshihara, 2017, The Journal of dermatology.

Certolizumab Pegol for the Treatment of Moderate to Severe Plaque Psoriasis: 16-Week Results from a Phase 2/3 Japanese Study

H. Nakagawa, Y. Umezawa, S. Sakurai, 2021, Dermatology and Therapy.

Association of Cw11 in Japanese patients with psoriasis vulgaris.

S. Akazaki, H. Nakagawa, K. Tokunaga, 1990, Tissue antigens.

Session I: Allergy and Genes Lack of primary association between transporter associated with antigen processing genes and atopic dermatitis

H. Nakagawa, K. Tokunaga, T. Juji, 1995 .

Malignant schwannoma with melanocytic differentiation arising in a patient with neurofibromatosis

H. Nakagawa, T. Kiyosawa, S. Murata, 2000, The British journal of dermatology.

Epidemiological survey of patients with psoriasis in Matsumoto city, Nagano Prefecture, Japan

H. Nakagawa, A. Kawada, M. Muto, 2018, The Journal of dermatology.

Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis

H. Nakagawa, K. Kuwano, Y. Umezawa, 2021, PloS one.

Interstitial Pneumonia in Psoriasis

H. Nakagawa, K. Kuwano, Y. Kaneko, 2018, Mayo Clinic proceedings. Innovations, quality & outcomes.

Synergistic effect of PDGF and FGF2 for cell proliferation and hair inductive activity in murine vibrissal dermal papilla in vitro.

H. Nakagawa, M. Itoh, H. Okochi, 2015, Journal of dermatological science.

Chronologic analysis of in situ cytokine expression in mite allergen-induced dermatitis in atopic subjects.

H. Nakagawa, S. Kuwata, T. Yoshida, 1995, The Journal of allergy and clinical immunology.

003 Chronologcal analysis of in situ cytokine expression in mite-allergen induced dermatitis inatopic subjects

H. Nakagawa, K. Tamaki, S. Kuwata, 1995 .

Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: A randomized, double‐blind, placebo‐controlled trial

H. Nakagawa, Y. Umezawa, K. Tamaki, 2016, The Journal of dermatology.

Suppressive Effects of Mesenchymal Stem Cells in Adipose Tissue on Allergic Contact Dermatitis

H. Nakagawa, Y. Tada, K. Yanaba, 2017, Annals of dermatology.

Vasoactive intestinal peptide and cytokines enhance stem cell factor production from epidermal keratinocytes DJM-1.

H. Nakagawa, Y. Furukawa, S. Ishibashi, 2002, The Journal of investigative dermatology.

Follicular mucinosis: a detailed morphologic and immunopathologic study.

M. Mihm, H. Nakagawa, B. Bronstein, 1984, Journal of the American Academy of Dermatology.

Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits

H. Nakagawa, M. Ohtsuki, H. Morimoto, 2018, The Journal of dermatology.

An accumulation of glucosylceramide in the stratum corneum due to attenuated activity of beta-glucocerebrosidase is associated with the early phase of UVB-induced alteration in cutaneous barrier function

H. Nakagawa, Y. Takema, G. Imokawa, 2005, Archives of Dermatological Research.

Changes in eosinophil and leukocyte infiltration and expression of IL-6 and IL-7 messenger RNA in mite allergen patch test reactions in atopic dermatitis.

H. Nakagawa, S. Kuwata, K. Tamaki, 1996, The Journal of allergy and clinical immunology.

Japanese sporadic case of erythrokeratodermia variabilis caused by the connexin‐30.3 (GJB4) mutation: Is Glycine 12 a mutational hotspot in the connexin family?

H. Nakagawa, M. Itoh, Yumie Yoshikata-Isokawa, 2016, The Journal of dermatology.

Tacrolimus Has Antifungal Activities against Malassezia furfur Isolated from Healthy Adults and Patients with Atopic Dermatitis

H. Nakagawa, Y. Yokota, F. Ikeda, 1996 .

Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52‐week analysis from phase III open‐label multicenter Japanese study

H. Nakagawa, M. Honma, M. Komine, 2016, The Journal of dermatology.

Interstitial pneumonia in two patients with psoriasis during ustekinumab treatment

H. Nakagawa, Y. Umezawa, K. Yanaba, 2016, The Journal of dermatology.

Serum levels of soluble programmed death‐1 and programmed death ligand‐1 in systemic sclerosis: Association with extent of skin sclerosis

H. Nakagawa, K. Yanaba, Yuki Yoshihara, 2016, The Journal of dermatology.

Relationship between the Degrees of Itch and Serum Lipocalin-2 Levels in Patients with Psoriasis

H. Nakagawa, Y. Umezawa, K. Takamori, 2019, Journal of immunology research.

Long‐term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5‐year extension of a phase 3 study (reSURFACE 1)

H. Nakagawa, M. Ohtsuki, S. Imafuku, 2021, The Journal of dermatology.

Predominant cell-mediated immunity in the oral mucosa: gene gun-based vaccination against infectious diseases.

H. Nakagawa, M. Kusama, M. Ohtsuki, 2003, Journal of dermatological science.

Serum levels of vasoactive intestinal peptide are elevated in patients with atopic dermatitis.

H. Nakagawa, T. Kiyosawa, T. Demitsu, 2003, Journal of dermatological science.

Malignant melanoma and vitiligo-like leukoderma: an electron microscopic study.

M. Mihm, T. Fitzpatrick, H. Nakagawa, 1983, Journal of the American Academy of Dermatology.

Taxane‐induced scleroderma

H. Nakagawa, M. Itoh, K. Yanaba, 2007, The British journal of dermatology.

Decreased levels of covalently bound ceramide are associated with ultraviolet B-induced perturbation of the skin barrier.

H. Nakagawa, Y. Takema, G. Imokawa, 2004, The Journal of investigative dermatology.

A survey of psoriasis patients in Japan from 1982 to 2001.

H. Nakagawa, A. Kawada, T. Tezuka, 2003, Journal of dermatological science.

Usefulness of dual‐energy computed tomography for the evaluation of early‐stage psoriatic arthritis only accompanied by nail psoriasis

H. Nakagawa, Y. Umezawa, K. Yanaba, 2017, The Journal of dermatology.

Case of lymph node primary perivascular epithelioid cell tumor associated with leukoderma

H. Nakagawa, Y. Nobeyama, Sachiko Tajima-Kondo, 2017, The Journal of dermatology.

Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results

H. Nakagawa, Y. Umezawa, S. Sakurai, 2022, Dermatology and Therapy.

Secukinumab in plaque psoriasis--results of two phase 3 trials.

B. Elewski, M. Lebwohl, H. Nakagawa, 2014, The New England journal of medicine.

Inhibition of ultraviolet‐B‐induced wrinkle formation by an elastase‐inhibiting herbal extract: implication for the mechanism underlying elastase‐associated wrinkles

H. Nakagawa, Y. Takema, G. Imokawa, 2005, International journal of dermatology.

Case of papuloerythroderma of Ofuji‐like eruption during the course of bullous pemphigoid

H. Nakagawa, A. Asahina, Y. Nobeyama, 2017, The Journal of dermatology.

Tacrolimus ointment for atopic dermatitis

H. Nakagawa, Y. Ishibashi, T. Etoh, 1994, The Lancet.

Tacrolimus concentrations in blood during topical treatment of atopic dermatitis

H. Nakagawa, M. Ohtsuki, M. Kawashima, 1996, The Lancet.

IgA pemphigus occurring in a 1-month-old infant.

H. Nakagawa, S. Murata, Y. Kobori, 2003, Journal of the American Academy of Dermatology.

Pityriasis rotunda associated with multiple myeloma.

H. Nakagawa, Y. Ishibashi, T. Etoh, 1991, Journal of the American Academy of Dermatology.

Efficacy and safety of ustekinumab in Japanese patients with moderate‐to‐severe plaque‐type psoriasis: Long‐term results from a phase 2/3 clinical trial

H. Nakagawa, A. Igarashi, Takeshi Kato, 2012, The Journal of dermatology.

Japanese Ustekinumab Study. Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: longterm results from a phase II/III clinical trial

H. Nakagawa, A. Igarashi, Takeshi Kato, 2011 .

Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002–2008

H. Nakagawa, Koichiro Nakamura, Hidetoshi Takahashi, 2011, The Journal of dermatology.

Development and validation of a questionnaire measuring quality of life in primary caregivers of children with atopic dermatitis (QPCAD)

H. Nakagawa, Y. Ohya, T. Katsunuma, 2009, The British journal of dermatology.

Comparison of the Efficacy and Safety of 0.1% Tacrolimus Ointment with Topical Corticosteroids in Adult Patients with Atopic Dermatitis

H. Nakagawa, 2006, Clinical drug investigation.

Development of Tacrolimus Ointment

H. Nakagawa, T. Goto, 2004 .

A CASE OF CRYPTOCOCCAL SUBCUTANEOUS ABSCESS CAUSED BY PRIMARY OSSEOUS CRYPTOCOCCOSIS

H. Nakagawa, K. Takizawa, Kuniaki Ohhara, 1979, The Journal of dermatology.

Subcutaneous Nocardial Abscesses in a Patient with Bullous Pemphigoid during Immunosuppressive Therapy: Report of a Case and Review of the Japanese Literature

H. Nakagawa, T. Kiyosawa, M. Kakurai, 1999, The Journal of dermatology.

Subcutaneous Sweet's syndrome and neutrophilic panniculitis

H. Nakagawa, Y. Nobeyama, 2014, The Journal of dermatology.

Drug survival rates in patients with psoriasis after treatment with biologics

H. Nakagawa, Y. Umezawa, H. Saeki, 2013, The Journal of dermatology.

Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database

Daisuke Koide, Hajime Iizuka, Kiyoshi Kubota, 2015, BMJ Open.

Osteosarcomatous changes in malignant melanoma. Immunohistochemical and ultrastructural studies of a case.

H. Nakagawa, S. Imakado, Y. Ishibashi, 1990, The American Journal of dermatopathology.

Eradication of metastatic angiosarcoma of the lower extremity. Case report.

H. Nakagawa, M. Fujimoto, T. Kiyosawa, 2000, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

Deficient Production of Hexadecenoic Acid in the Skin Is Associated in Part with the Vulnerability of Atopic Dermatitis Patients to Colonization by Staphylococcus aureus

H. Nakagawa, G. Imokawa, H. Mori, 2005, Dermatology.

Metastatic masseter muscle tumour: a report of a case

H. Nakagawa, N. Kuwayama, Y. Mizukami, 1996, The Journal of Laryngology & Otology.

Case of ecthyma gangrenosum in which only methicillin‐resistant Staphylococcus epidermidis was detected

H. Nakagawa, S. Miyake, Y. Nobeyama, 2016, The Journal of dermatology.

Expression of simple epithelial keratins in epidermal neoplasia is not directly and exclusively related to malignancy.

H. Nakagawa, M. Furue, Y. Ishibashi, 1992, The Journal of investigative dermatology.

Simple epithelial cytokeratin‐expression in seborrheic keratosis

H. Nakagawa, M. Furue, Y. Ishibashi, 1992, Journal of cutaneous pathology.

Epidemiology and Health Services Research Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, U.S.A. and U.K

H. Nakagawa, M. Kawashima, S. Stevens, 2002 .

Treatment of Atopic Dermatitis with Immunomodulatory Drugs

H. Nakagawa, 2002 .

Control of inflammation in atopic dermatitis.

H. Nakagawa, 2000 .

Unusual parotid gland foreign body.

H. Nakagawa, Y. Watanabe, H. Kimura, 1999, International journal of pediatric otorhinolaryngology.

Aberrant DNA Methylation in Keratoacanthoma

H. Nakagawa, Y. Nobeyama, 2016, PloS one.

Characterization of melanogenesis in normal human epidermal melanocytes by chemical and ultrastructural analysis.

H. Nakagawa, G. Imokawa, 1996, Pigment cell research.

Difference in clinical features and HLA antigens between familial and non‐familial vitiligo of non‐segmental type

H. Nakagawa, H. Chi, I. Ando, 1993, The British journal of dermatology.

Amelanotic metastatic melanoma in a patient with oculocutaneous albinism.

H. Nakagawa, H. Ihn, M. Furue, 1993, Journal of the American Academy of Dermatology.

The nature and origin of the melanin macroglobule.

R. Martuza, T. Fitzpatrick, H. Nakagawa, 1984, The Journal of investigative dermatology.

Acid phosphatase in melanosome formation: a cytochemical study in normal human melanocytes.

T. Fitzpatrick, H. Nakagawa, A. Rhodes, 1984, The Journal of investigative dermatology.

Morphologic alterations of epidermal melanocytes and melanosomes in PUVA lentigines: a comparative ultrastructural investigation of lentigines induced by PUVA and sunlight.

T. Fitzpatrick, H. Nakagawa, A. Rhodes, 1984, The Journal of investigative dermatology.

Naevus fusco‐caeruleus zygomaticus

H. Nakagawa, Y. Lü, Chee‐ching Sun, 1987, The British journal of dermatology.

Ovariectomy is sufficient to accelerate spontaneous skin ageing and to stimulate ultraviolet irradiation‐induced photoageing of murine skin

H. Nakagawa, Y. Takema, G. Imokawa, 2004, The British journal of dermatology.

Condyloma acuminatum of the nipple and areola

H. Nakagawa, M. Ohtsuki, H. Saeki, 2014, International journal of dermatology.

Neutrophil–lymphocyte ratio, platelet–lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics

H. Nakagawa, Y. Umezawa, K. Yanaba, 2017, The Journal of dermatology.

Real-World Postmarketing Study of the Impact of Adalimumab Treatment on Work Productivity and Activity Impairment in Patients with Psoriatic Arthritis

H. Nakagawa, A. Taniguchi, Yoshiya Tanaka, 2019, Advances in Therapy.

New onset or transition of disease state of psoriatic arthritis during treatment with ustekinumab: A single‐center retrospective study

H. Nakagawa, Y. Umezawa, K. Yanaba, 2017, The Journal of dermatology.

Large tonsillolith mimicking peritonsillar abscess: a case report.

H. Nakagawa, H. Kimura, N. Ohashi, 1993, Auris, nasus, larynx.

Clinical features of 58 Japanese patients with mosaic neurofibromatosis 1

H. Nakagawa, A. Ota, K. Tanito, 2014, The Journal of dermatology.

Silencing of G0/G1 switch gene 2 in cutaneous squamous cell carcinoma

H. Nakagawa, Y. Nobeyama, Yoshinori Watanabe, 2017, PloS one.

Lack of primary association between transporter associated with antigen processing genes and atopic dermatitis.

H. Nakagawa, K. Tokunaga, T. Juji, 1995, The Journal of allergy and clinical immunology.

Polymorphisms of transporter associated with antigen processing genes in atopic dermatitis.

H. Nakagawa, K. Tokunaga, T. Juji, 1994, The Journal of allergy and clinical immunology.

Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus.

X. Estivill, J. Kere, S. Ripatti, 2002, Human molecular genetics.

Successful treatment of disseminated superficial actinic porokeratosis with Q‐switched ruby laser

H. Nakagawa, M. Itoh, 2007, The Journal of dermatology.

Mechanism of Macrophage-Derived Chemokine/CCL22 Production by HaCaT Keratinocytes

H. Nakagawa, M. Komine, M. Ohtsuki, 2015, Annals of dermatology.

Giant acquired digital fibrokeratoma.

H. Nakagawa, M. Ohtsuki, T. Kiyosawa, 2003, Journal of the American Academy of Dermatology.

[Dynamic aspects of cultured epidermal cells in Hailey-Hailey's disease (author's transl)].

H. Nakagawa, Y. Ishibashi, A. Kukita, 1979, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology.

Loop‐mediated isothermal amplification method for detection of human papillomavirus type 6, 11, 16, and 18

H. Nakagawa, M. Honda, M. Kawase, 2007, Journal of medical virology.

Extragenital subcutaneous cellular angiofibroma of the elbow

H. Nakagawa, A. Ota, Y. Umezawa, 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

Silencing of metallothionein 1A gene in melanoma.

H. Nakagawa, Y. Nobeyama, 2017, Journal of dermatological science.

Usefulness of dual‐energy computed tomography for the evaluation of psoriatic arthritis accompanied by knee osteoarthritis

H. Nakagawa, Y. Umezawa, K. Yanaba, 2018, Journal of dermatology (Print).

Expression profiling of cancer-related genes in human keratinocytes following non-lethal ultraviolet B irradiation.

H. Nakagawa, M. Fujimoto, T. Murakami, 2001, Journal of dermatological science.

Brodalumab, a human anti-interleukin-17-receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: Efficacy and safety results from a phase II randomized controlled study.

H. Nakagawa, H. Niiro, K. Ootaki, 2016, Journal of dermatological science.

Initial Experience of Using Dual-Energy CT with an Iodine Overlay Image for Hand Psoriatic Arthritis: Comparison Study with Contrast-enhanced MR Imaging.

H. Nakagawa, Y. Umezawa, A. Asahina, 2017, Radiology.

Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52‐week, open‐label study

H. Nakagawa, Y. Kubo, K. Ootaki, 2017, The British journal of dermatology.

Expressions of Various Growth Factors and Their Receptors in Tissues from Neurofibroma

H. Nakagawa, T. Kadono, K. Tamaki, 2000, Dermatology.

A female case of benign symmetric lipomatosis associated with alcoholism

H. Nakagawa, Y. Ishiuji, Mami Fukasawa, 2014, European Journal of Dermatology.

Keratin Expression in Merkel Cells of Fetal Rat Skin

H. Nakagawa, Y. Ishibashi, M. Nindl, 1991, The Journal of dermatology.

Symmetric Lipomatosis of the Tongue: Report of a Case

H. Nakagawa, Takuma Tsukahara, Y. Jinbu, 2004 .

Syringocystadenoma papilliferum on the dorsum of the foot

H. Nakagawa, Y. Nobeyama, Yoshihiko Ito, 2013, The Journal of dermatology.

A case of angioedema associated with decreased C1 inhibitor activity.

H. Nakagawa, A. Ota, Chizuko Yano, 2007, Allergology International.

Chronologic analysis of eosinophil granule protein deposition and cell adhesion molecule expression in mite allergen-induced dermatitis in atopic subjects.

H. Nakagawa, K. Tamaki, M. Wakugawa, 1996, International archives of allergy and immunology.

Histone deacetylase inhibitor FK228 suppresses the Ras–MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma

H. Nakagawa, H. Kitayama, Y. Furukawa, 2006, Oncogene.

Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families.

H. Nakagawa, T. Arinami, F. Otsuka, 1998, Journal of medical genetics.

Spontaneous regression of Merkel cell carcinoma developed in a patient with epidermodysplasia verruciformis

H. Nakagawa, Koji Matsumoto, T. Ishiji, 2014, The Journal of dermatology.

A Case of Advanced Extramammary Paget's Disease Successfully Controlled by Monthly but Not Weekly Docetaxel Chemotherapy

H. Nakagawa, M. Itoh, Y. Nobeyama, 2016, Case Reports in Oncology.

Metastatic Behavior and Tumorigenicity of a Human Melanoma Cell Line (MM‐RU) after Injection into Nude Mice

H. Nakagawa, G. Imokawa, H. Byers, 1993, The Journal of dermatology.

Ultrastructural changes in human skin after exposure to a pulsed laser.

J. Parrish, H. Nakagawa, O. Tan, 1985, The Journal of investigative dermatology.

Variants at HLA-A, HLA-C, and HLA-DQB1 Confer Risk of Psoriasis Vulgaris in Japanese.

M. Kanai, Y. Okada, Toshihiro Tanaka, 2017, The Journal of investigative dermatology.

Study of HLA class I, class II and complement genes (C2, C4A, C4B and BF) in Japanese psoriatics and analysis of a newly-found high-risk haplotype by pulsed field gel electrophoresis

S. Akazaki, H. Nakagawa, K. Tokunaga, 2004, Archives of Dermatological Research.

Cutaneous composite hemangioendothelioma on the nose treated with electron beam

H. Nakagawa, M. Fukunaga, H. Saeki, 2013, International journal of dermatology.

Role of interleukin‐24 in the tumor‐suppressive effects of interferon‐β on melanoma

H. Nakagawa, M. Itoh, A. Asahina, 2019, Experimental dermatology.

Tumor-suppressive effects of natural-type interferon-β through CXCL10 in melanoma.

H. Nakagawa, Y. Nobeyama, Hikaru Kobayashi, 2015, Biochemical and biophysical research communications.

Adalimumab treatment in Japanese patients with generalized pustular psoriasis: Results of an open‐label phase 3 study

H. Nakagawa, Y. Hasegawa, S. Imafuku, 2018, The Journal of dermatology.

Switching of biologics in psoriasis: Reasons and results

H. Nakagawa, Y. Umezawa, K. Yanaba, 2017, The Journal of dermatology.

Silencing of interferon regulatory factor gene 6 in melanoma

H. Nakagawa, Y. Nobeyama, 2017, PloS one.

Long‐term clinical efficacy and safety of secukinumab for Japanese patients with psoriasis: A single‐center experience

H. Nakagawa, Y. Umezawa, A. Asahina, 2018, The Journal of dermatology.

Japanese guidance for use of biologics for psoriasis (the 2013 version)

H. Nakagawa, Hidetoshi Takahashi, M. Komine, 2013, The Journal of dermatology.

Epidemiological survey from 2009 to 2012 of psoriatic patients in Japanese Society for Psoriasis Research

H. Nakagawa, Hidetoshi Takahashi, A. Kawada, 2018, The Journal of dermatology.

Long‐term clinical safety and efficacy of brodalumab in the treatment of Japanese patients with moderate‐to‐severe plaque psoriasis

H. Nakagawa, H. Niiro, Y. Umezawa, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study

H. Nakagawa, M. Ohtsuki, R. Langley, 2023, Dermatology and Therapy.

Aberrant demethylation and expression of MAGEB2 in a subset of malignant peripheral nerve sheath tumors from neurofibromatosis type 1.

H. Nakagawa, Y. Nobeyama, 2016, Journal of dermatological science.

Rupioid psoriasis with arthropathy

H. Nakagawa, T. Murakami, M. Ohtsuki, 2000, Clinical and experimental dermatology.

Synergistic Effects of Hyperthermia and Peplomycin against Human Malignant Melanoma Xenografts

H. Nakagawa, Y. Ishibashi, T. Etoh, 1988, The Journal of dermatology.

Adalimumab markedly improves enthesitis in patients with psoriatic arthritis: Evaluation with a magnetic resonance imaging scoring system

H. Nakagawa, Y. Umezawa, K. Yanaba, 2015, The Journal of dermatology.

Safety profiles and efficacy of infliximab therapy in Japanese patients with plaque psoriasis with or without psoriatic arthritis, pustular psoriasis or psoriatic erythroderma: Results from the prospective post‐marketing surveillance

H. Nakagawa, M. Ohtsuki, H. Torii, 2016, The Journal of dermatology.

Ultrastructural study on melanogenesis of follicular melanocytes in the new born beige mice

H. Nakagawa, Y. Ishibashi, Ryôji Watanabe, 1986 .

Intermittent hair follicle dystrophy

H. Nakagawa, B. Bronstein, H. Baden, 1986 .

An Immunohistochemical Study

H. Nakagawa, H. Torii, Y. Ishibashi, 2015 .

Penicillamine‐Induced Degenerative Dermatoses: Report of a Case and Brief Review of Such Dermatoses

H. Nakagawa, K. Iozumi, K. Tamaki, 1997, The Journal of dermatology.

Nodular fasciitis on the face

H. Nakagawa, R. Nishimura, K. Yanaba, 2016, The Journal of dermatology.

A case of humeral interval node metastasis of malignant melanoma in the right thumb

H. Nakagawa, O. Fukuchi, Koma Matsuo, 2009 .

Case of collagenous fibroma (desmoplastic fibroblastoma) with vascular hyperplasia in the boundary area detected by Doppler sonography and histopathological examination

H. Nakagawa, Y. Nobeyama, Yukari Tofuku, 2015, The Journal of dermatology.

Generation of induced pluripotent stem cell (iPSC) from NY‐ESO‐I‐specific cytotoxic T cells isolated from the melanoma patient with minor HLAs: The practical pilot study for the adoptive immunotherapy for melanoma using iPSC technology

H. Nakagawa, H. Okano, M. Itoh, 2022, Experimental dermatology.

Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis

H. Nakagawa, Y. Umezawa, H. Saeki, 2014, The Journal of dermatology.

Ustekinumab treatment in patients with psoriasis undergoing hemodialysis

H. Nakagawa, Y. Umezawa, K. Yanaba, 2015, The Journal of dermatology.

Correlation of telomere length to malignancy potential in non-melanoma skin cancers.

H. Nakagawa, Y. Nobeyama, Hanae Yamada-Hishida, 2017, Oncology letters.

Examination of the correlation between the manual and automated serological testing methods for syphilis

H. Nakagawa, A. Iwamoto, M. Honda, 2012, The Journal of dermatology.

A Case of Subcutaneous Malignant Fibrous Histiocytoma Circumscribed by Fibrous Tissue

H. Nakagawa, K. Tamaki, T. Etoh, 1996, The Journal of dermatology.

Skin ultrasound examination proves useful in diagnosing two cases of solid cystic hidradenoma

H. Nakagawa, H. Saeki, T. Ishiji, 2014, International journal of dermatology.

Genetic polymorphisms in HLA-A, -B, -C and -DR antigens in Japanese patients with palmoplantar pustulosis.

H. Nakagawa, K. Tokunaga, T. Juji, 1994, Dermatology.

Antinuclear antibody formation following administration of anti‐tumor necrosis factor agents in Japanese patients with psoriasis

H. Nakagawa, Y. Umezawa, K. Yanaba, 2016, The Journal of dermatology.

Blue rubber-bleb nevus syndrome with hypertrophic cardiomyopathy.

H. Nakagawa, T. Serizawa, Y. Ishibashi, 1988 .

Abstracts of Oral Presentations

T. Tadakuma, H. Nakagawa, H. Nawashiro, 2008, Human Cell.

Japanese families . gene polymorphism with atopic dermatitis in Linkage and association of an interleukin 4

H. Nakagawa, T. Arinami, F. Otsuka, 2022 .

Female case of nevus lipomatosus cutaneous superficialis growing depending on the occurrence site

H. Nakagawa, Yuki Sato, Y. Nobeyama, 2017, Journal of dermatology (Print).

Impact of disease severity on sleep quality in Japanese patients with atopic dermatitis.

H. Nakagawa, J. Sato, H. Saeki, 2013, Journal of dermatological science.

Novel IL36RN gene mutation revealed by analysis of 8 Japanese patients with generalized pustular psoriasis.

H. Nakagawa, S. Fujieda, Y. Umezawa, 2014, Journal of dermatological science.

Guselkumab, a human interleukin‐23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52‐week, phase 3, multicenter, open‐label study

H. Nakagawa, S. Sano, Ryosuke Goto, 2018, The Journal of dermatology.

Comment on "Efficacy and safety of etanercept and adalimumab with and without a loading dose for psoriasis: A systematic review".

H. Nakagawa, A. Asahina, 2017, Journal of the American Academy of Dermatology.

Dual energy CT iodine map for delineating inflammation of inflammatory arthritis

H. Nakagawa, Y. Umezawa, A. Asahina, 2017, European Radiology.

Fexofenadine is effective at reducing itching associated with atopic dermatitis

T. Tango, H. Nakagawa, M. Kawashima, 2002 .

Biosynthesis of acylceramide in murine epidermis: characterization by inhibition of glucosylation and deglucosylation, and by substrate specificity.

H. Nakagawa, G. Imokawa, Y. Takagi, 2004, The Journal of investigative dermatology.

Effect of Epinastine Hydrochloride, a Second-generation Histamine H1-receptor Antagonist, on Sensory Neurons in vitro

H. Nakagawa, M. Morohashi, M. Toyoda, 2005 .

Cutaneous apocrine carcinoma on the scalp after cranial irradiation for acute lymphocytic leukaemia

H. Nakagawa, M. Itoh, Y. Nobeyama, 2016, European Journal of Dermatology.

Secukinumab improves psoriasis symptoms in patients with inadequate response to cyclosporine A: A prospective study to evaluate direct switch

H. Nakagawa, M. Ohtsuki, S. Imafuku, 2017, The Journal of dermatology.

Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis

H. Nakagawa, J. Sato, H. Saeki, 2013, The Journal of dermatology.

Case of linear immunoglobulin A/immunoglobulin G bullous dermatosis showing immunoglobulin G reactivity with the 120‐kDa LAD‐1

H. Nakagawa, T. Hashimoto, A. Asahina, 2017, The Journal of dermatology.

Case of spindle cell squamous cell carcinoma with dermoscopic findings of diffuse/discrete scales and predominant white color

H. Nakagawa, S. Tomita, Y. Nobeyama, 2016, The Journal of dermatology.

Risk of herpes zoster in psoriatic patients undergoing biologic treatment

H. Nakagawa, Y. Umezawa, H. Saeki, 2014, The Journal of dermatology.

Safety and efficacy of adalimumab treatment in Japanese patients with psoriasis: Results of SALSA study

H. Nakagawa, M. Ohtsuki, H. Hase, 2016, The Journal of dermatology.

Acquired hemophilia A and fulminant diabetes mellitus possibly caused by adalimumab in a patient with psoriatic arthritis

H. Nakagawa, Y. Umezawa, M. Itoh, 2017, The Journal of dermatology.

Desmoplastic Malignant Melanoma

H. Nakagawa, Ai-Young Lee, M. Kawashima, 1988, The Journal of dermatology.

Human papillomavirus type 6/11 identified in an epidermoid cyst of the scrotum

H. Nakagawa, K. Egawa, T. Ishiji, 2018, The Journal of dermatology.

Case of deep dissecting hematoma resulting in sepsis due to Pseudomonas aeruginosa infection

H. Nakagawa, Y. Nobeyama, Sachiko Tajima-Kondo, 2018, Journal of dermatology (Print).

A case of deep dissecting hematoma: different managements resulting in similar outcomes

H. Nakagawa, M. Itoh, Y. Nobeyama, 2016, International journal of dermatology.

Anti‐transcription intermediary factor‐1γ/α/β antibody‐positive dermatomyositis associated with multiple panniculitis lesions

H. Nakagawa, K. Tanito, K. Yanaba, 2017, International journal of rheumatic diseases.

IL-10-Producing Regulatory B Cells Are Decreased in Patients with Atopic Dermatitis.

H. Nakagawa, K. Yanaba, A. Yoshizaki, 2019, The Journal of investigative dermatology.

Thymoma-associated cutaneous graft-versus-host-like disease possibly treated with narrow-band UVB phototherapy

H. Nakagawa, K. Tanito, M. Itoh, 2016, European Journal of Dermatology.

A Case of Nonscarring Subepidermal Blistering Disease Associated with Autoantibodies Reactive with Both Type VII Collagen and Laminin 5

H. Nakagawa, T. Hashimoto, Masayuki Suzuki, 2003, Dermatology.

Squamous cell carcinoma arising on scars of epidermolysis bullosa acquisita

H. Nakagawa, M. Fujimoto, T. Kiyosawa, 2005, The British journal of dermatology.

Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection

H. Nakagawa, Y. Umezawa, K. Teruya, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Interferon-gamma-induced RANTES production by human keratinocytes is enhanced by IL-1beta, TNF-alpha, IL-4 and IL-13 and is inhibited by dexamethasone and tacrolimus.

H. Nakagawa, K. Nakamura, M. Akatsuka, 2001, Dermatology.

HLA and atopic dermatitis with high serum IgE levels.

H. Nakagawa, K. Tokunaga, T. Juji, 1994, The Journal of allergy and clinical immunology.

Comparative study of FK506(tacrolimus) ointment vs. alclometasone dipropionate ointment in atopic dermatitis (face and neck lesions)

H. Nakagawa, 1998 .

Characterization of Surfactant-Induced Skin Damage through Barrier Recovery Induced by Pseudoacylceramides

H. Nakagawa, G. Imokawa, K. Higuchi, 2005, Dermatology.

A Case of Radiation-Induced Generalized Morphea with Prominent Mucin Deposition and Tenderness

H. Nakagawa, Y. Umezawa, K. Yanaba, 2015, The American journal of case reports.

Recurrent neutrophilic dermatosis of the face: A report of two cases and review of the published work

H. Nakagawa, Y. Umezawa, K. Yanaba, 2016, The Journal of dermatology.

Bowen's carcinoma of the penis with sebaceous differentiation associated with human papillomavirus type 16

H. Nakagawa, K. Tanito, H. Saeki, 2014, International journal of dermatology.

Relapsing polychondritis associated with psoriasis vulgaris successfully treated with adalimumab: A case report with published work review

H. Nakagawa, Y. Umezawa, A. Asahina, 2017, The Journal of dermatology.

Cutaneous plasmacytosis successfully treated with narrowband ultraviolet B irradiation therapy

H. Nakagawa, Y. Umezawa, K. Yanaba, 2016, Journal of dermatology (Print).

Retinoids 10 Years On

C. Brun-Buisson, R. Happle, H. Nakagawa, 1990 .

Multiple lesions of granuloma annulare following BCG vaccination: case report and review of the literature

H. Nakagawa, M. Ohtsuki, T. Kiyosawa, 2001, International journal of dermatology.

Palisaded neutrophilic and granulomatous dermatitis in a rheumatoid arthritis patient after treatment with adalimumab.

H. Nakagawa, Y. Umezawa, Keigo Ito, 2013, EJD. European journal of dermatology.

Systemic elastolytic granulomatosis with cutaneous, ocular, lymph nodal, and intestinal involvement. Spectrum of annular elastolytic giant cell granuloma and sarcoidosis.

H. Nakagawa, M. Furue, K. Iozumi, 1992, Journal of American Academy of Dermatology.

A Case of 3-mm-Sized Superficial Spreading Melanoma in Situ

H. Nakagawa, H. Ihn, Shin'ichi Sato, 1993 .

Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.

H. Nakagawa, H. Okano, K. Tamai, 2020, Journal of dermatological science.

A Consensus Conference Report on Psoriasis Therapy with Cyclosporine MEPC

H. Nakagawa, H. Iizuka, M. Ohtsuki, 2004 .

MAGEA3 methylation status is associated with prognosis of malignant peripheral nerve sheath tumor and with neurofibroma type in neurofibromatosis type 1.

H. Nakagawa, Y. Nobeyama, 2016, Journal of dermatological science.

A case of Miescher's type of acral melanocytic nevus

H. Nakagawa, Y. Nobeyama, 2014, The Journal of dermatology.

Comparison of two therapeutic regimens, continuous monotherapy and intermittent therapy, for long-term maintenance of remission of psoriasis with cyclosporin A

H. Nakagawa, J. Nakayama, T. Horikoshi, 1996 .

Cyclosporin in psoriasis: continuous monotherapy versus intermittent long-term therapy.

H. Nakagawa, K. Urabe, K. Jimbow, 1999, EJD. European journal of dermatology.

Patient satisfaction and efficacy of calcipotriol plus betamethasone dipropionate gel in plaque psoriasis patients with poor adherence

H. Nakagawa, Hidetoshi Takahashi, K. Tanito, 2020, The Journal of dermatology.

Efficacy of Maxacalcitol Lotion in Place of Other Topically Applied Lotions for Psoriasis Vulgaris of the Scalp

H. Nakagawa, M. Komine, M. Ohtsuki, 2010 .

Juvenile dermatomyositis positive for anti-DNA mismatch repair enzyme antibodies

H. Nakagawa, K. Yanaba, Y. Muro, 2017, European Journal of Dermatology.

Gene expression profile in a case of primary cutaneous CD30‐negative large T‐cell lymphoma with a blastic phenotype

H. Nakagawa, M. Fukayama, T. Fukasawa, 2001, Clinical and experimental dermatology.

The Effect of Metharmon-F for the Female Patients with Acne Vulgaris and Hormone Levels

H. Nakagawa, S. Imakado, A. Igarashi, 1994 .

Case of metachronous and multifocal extramammary Paget's disease

H. Nakagawa, M. Itoh, Y. Nobeyama, 2016, The Journal of dermatology.

Efficacy and Safety of Fexofenadine Hydrochloride in Pediatric Patients with Atopic Dermatitis in a Phase III, Randomized, Double-blind, Multi-center Comparative Study

H. Nakagawa, M. Kawashima, 2006 .

A Comparative Study of Maxacalcitol Monotherapy, Clobetasol Propionate Monotherapy and the Combination of Each Agent as a Premixed Ointment for the Treatment of Psoriasis

H. Nakagawa, Yoshihiko Ito, 2005 .

Case of pityriasis rubra pilaris with focal acantholytic dyskeratosis

H. Nakagawa, A. Asahina, Yuta Itoh, 2018, Journal of dermatology (Print).

Case of epidermal cyst on the glans penis

H. Nakagawa, Y. Nobeyama, 2013, The Journal of dermatology.

Acute onset vesiculo‐bullous dermatomyositis associated with massive mucosal necrosis of the intestines

H. Nakagawa, M. Fujimoto, S. Murata, 2002, Clinical and experimental dermatology.

Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes

H. Nakagawa, A. Menter, A. Costanzo, 2014, The British journal of dermatology.

Patient-relevant needs and treatment goals in nail psoriasis

H. Nakagawa, A. Menter, A. Costanzo, 2016, Quality of Life Research.

Uranaffin reaction in Merkel cells of fetal rat skin

H. Nakagawa, Y. Ishibashi, M. Nindl, 2004, Archives of Dermatological Research.

Serum KL‐6 levels in Japanese patients with psoriasis treated with secukinumab

H. Nakagawa, Y. Umezawa, K. Yanaba, 2018, The Journal of dermatology.

Infliximab and adalimumab, unlike ustekinumab, increase serum KL‐6 levels in Japanese patients with psoriasis

H. Nakagawa, Y. Umezawa, K. Yanaba, 2015, The Journal of dermatology.

Multiple clear cell acanthoma associated with multiple Bowen's disease

H. Nakagawa, H. Saeki, A. Shirai, 2014, International journal of dermatology.

Less-invasive analysis of DNA methylation using psoriatic scales.

H. Nakagawa, Y. Umezawa, Y. Nobeyama, 2016, Journal of dermatological science.

Diagnostically challenging case of low‐fat spindle cell lipoma

H. Nakagawa, Keigo Ito, 2015, Journal of dermatology (Print).

Angioimmunoblastic lymphadenopathy‐type peripheral T‐cell lymphoma with cutaneous infiltration: report of a case and its gene expression profile

H. Nakagawa, M. Ohtsuki, T. Murakami, 2001, The British journal of dermatology.

Generalized eruptive syringoma.

H. Nakagawa, M. Kawashima, Y. Ishibashi, 1991, Journal of the American Academy of Dermatology.

Serum levels of soluble programmed death-1 and programmed death ligand-1 in systemic sclerosis: Association with extent of skin sclerosis.

H. Nakagawa, K. Yanaba, Yuki Yoshihara, 2016, The Journal of dermatology.

Impact of disease severity on work productivity and activity impairment in Japanese patients with psoriasis.

H. Nakagawa, K. Tanito, Y. Umezawa, 2013, Journal of dermatological science (Amsterdam).

Anti-SAE Antibody-Positive Dermatomyositis in a Japanese Patient: A Case Report and Review of the Literature.

H. Nakagawa, Y. Umezawa, K. Yanaba, 2018, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Silencing of homeobox A5 gene in the stratum corneum of psoriasis

H. Nakagawa, Y. Umezawa, Y. Nobeyama, 2017, Experimental dermatology.

Genetic polymorphisms in the IL22 gene are associated with psoriasis vulgaris in a Japanese population.

Yusuke Nakamura, H. Nakagawa, S. Takeuchi, 2013, Journal of dermatological science.

Successful treatment by negative‐pressure wound therapy for ulcer located on diffuse plexiform neurofibroma

H. Nakagawa, Y. Nobeyama, H. Sekiyama, 2017, The Journal of dermatology.

Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study

H. Nakagawa, M. Ohtsuki, A. Asahina, 2010, The Journal of dermatology.

Osteoarthritis in 84 Japanese patients with palmoplantar pustulosis.

H. Nakagawa, H. Torii, Y. Ishibashi, 1994, Journal of the American Academy of Dermatology.

Erythema elevatum diutinum: an ultrastructural case study.

H. Nakagawa, Y. Ishibashi, T. Nogita, 1989, Journal of cutaneous pathology.

Anti‐PM/Scl antibody‐positive dermatomyositis in a Japanese patient: a case report and review of the literature

H. Nakagawa, Hideki Ito, K. Yanaba, 2017, International journal of rheumatic diseases.

Silencing of metallothionein 1A gene in melanoma.

H. Nakagawa, Y. Nobeyama, 2017, Journal of dermatological science.

Safety, efficacy, and pharmacokinetics of delgocitinib ointment in infants with atopic dermatitis: A phase 3, open-label, and long-term study.

H. Nakagawa, K. Kabashima, A. Igarashi, 2023, Allergology international : official journal of the Japanese Society of Allergology.